News & Trends - MedTech & Diagnostics
Cardiac arrhythmias: A review of current practices and emerging technologies
Coinciding with Atrial Fibrillation Awareness Week and the Asia-Pacific Heart Rhythm Society (APHRS) conference, Tanya Hall, CEO of hearts4heart, and A/Professor Chrishan Nalliah, Electrophysiologist at MQ Health, shed light on pressing issues in cardiac health and the future of patient care.
Hall shared how her personal journey and deep connection with patients emphasise the urgency of raising awareness about the condition.
“There are many patients that don’t have symptoms, and so sometimes it’s not until they have a stroke that it’s diagnosed. The other challenge is access to treatment. In some public hospitals, we have 1-2 year waiting lists for catheter ablation,” she explained.
A/Professor Nalliah delved into the advancements in the treatment of arrhythmias, highlighting how health technology innovations over the past decade have revolutionised patient care.
“The evidence is mounting that early and aggressive intervention, especially in the younger cohort, gives better outcomes,” he said. “The evolution of a new energy source when it comes to atrial fibrillation ablation – pulsed field ablation (PFA) – is also a therapeutic game changer.”
He also described the APHRS conference as the “convergence of science”, which promises to be a pivotal event for future breakthroughs in technology, clinical practice, and research in the heart rhythm field.
Smart devices, particularly the recent approval of smartwatches with ECG features by the Therapeutic Goods Administration (TGA), are playing an increasing role in empowering patients to take charge of their health. The duo discussed how these digital technologies are reshaping patient engagement and care.
As the conversation shifted to the the upcoming Federal election and the systemic challenges facing Australia’s public and private healthcare systems, A/Professor Nalliah and Hall called for bold reforms from policymakers to ensure healthcare is not only equitable but also affordable for all Australians.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More